Navigation Links
Markteinführung neuer Assays für Magen-Darm Infektionen in Europa
Date:4/17/2013

BALTIMORE und LÜTTICH, Belgien, 18. April 2013 /PRNewswire/ -- BD Diagnostics, ein Segment des weltweit tätigen Medizintechnikunternehmens BD (Becton, Dickinson and Company) und Diagenode SA, ein internationales Biotech-Unternehmen mit Sitz in Belgien, gaben heute bekannt, dass ab sofort das CE-zertifizierte Diagenode „Enteric Viral Panel primers and probes kit" verfügbar ist. Das Kit wird zusammen mit dem BD MAX(TM) RNA Extraktions-Kit RNA-3 und den BD MAX (TM) PCR Cartridges verwendet. Darüber hinaus wurde das CE-zertifizierte BD MAX(TM) „Enteric Bacterial Panel" für das BD MAX(TM) System angekündigt.

Das „Enteric Viral Panel primers and probes kit" von Diagenode ist ein automatisierter in vitro Diagnostik (IVD) Test. für den qualitativen Nachweis von unterschiedlichen Noro- (Genogruppen I und II) und Rota-Viren in Stuhlproben. Das „Enteric Bacterial Panel" ist ein qualitativer IVD-Test, der DNA von Campylobacter spp. (jejuni und coli), Salmonella spp., Shigellose (Shigella spp./Enteroinvasive E. coli [EIEC]) sowie von Shiga-Toxinen Typ 1a und 2a in Stuhlproben erkennt.

„Das erweiterbare ständig wachsende Produktangebot, die Einsatzmöglichkeit als offenes System, die Vollautomatisierung und der standardisierte Arbeitsablauf des BD MAX Systems ermöglicht es Laboren, eine Reihe von molekularen Tests zu konsolidieren und zu standardisieren. So können Programme zusammengestellt werden, die den aktuellen und zukünftigen klinischen Bedarf erfüllen", erklärte Tom Polen , Präsident, BD Diagnostics – Diagnostic Systems. „BDs Angebot an enterischen Assays für das BD MAX System ermöglicht es gezielt nach Patienten- und klinischen Bedürfnissen zu testen um  sowohl die klinischen als auch die wirtschaftlichen Ergebnisse z
'/>"/>

SOURCE BD-Becton Dickinson
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. invendo medical gibt Markteinführung für computergestütztes Koloskopiesystem zur einmaligen Verwendung nach spezieller 510(k)-Freigabe durch die US-Arzneimittelbehörde FDA bekannt
2. Pinnacle Biologics beantragt Zulassung neuer Indikationen in Deutschland und Frankreich
3. Profil Institute and Mercodia Announce Partnership Offering Insulin and Metabolism ELISA Assays to Enhance Diabetes and Obesity Clinical Trials
4. Genalyte Awarded $500,000 SBIR Grant To Develop Multiplexed Assays For Early Detection And Monitoring Of Type 1 Diabetes
5. ChanTest Awarded $1 Million Grant for Predictive Assays using Stem Cell-Derived Human Cardiomyocytes
6. Nuovi dati rivelano il crescente problema dellosteoporosi in Europa
7. Neue klinische Richtlinien für ältere Patienten mit Typ 2 Diabetes, um einen europaweiten Pflegenotstand zu verhindern
8. United BioSource Corp. erweitert mit entscheidender Neubesetzung Potenzial in Europa
9. Neue europaweite Umfrage Ergibt, dass die Behandlung chronischer Schmerzen bei vielen Patienten unzureichend ist
10. Spinifex Announces Start of Phase 2 Proof-of-Concept Trial of EMA401 in Chemotherapy-Induced Peripheral Neuropathy
11. Phase 3 Data Show NUCYNTA® ER (tapentadol) Extended-Release Tablets Provide Pain Management for Patients with Diabetic Peripheral Neuropathy (DPN)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... Aspire Technology Partners (Aspire) announced today that it has achieved ... recognizes Aspire for delivering outstanding customer service to customers in ... "Achieving exceptional results for our customers is core to ... CEO of Aspire. "We are pleased Cisco has recognized our ... are proud to be part of the Cisco channel." ...
(Date:8/1/2014)... Medical, Inc. (Nasdaq: NXTM ), a leading manufacturer ... Burbank , Chief Executive Officer, and Mathew Towse , ... Annual Canaccord Genuity Growth Conference being held at the InterContinental ... 13 th at 4:30 p.m. ET.  A webcast of ... About NxStage Medical NxStage Medical, ...
(Date:8/1/2014)... Aug. 1, 2014 Arena Pharmaceuticals, Inc. ... corporate update and reported financial results for the ... "We have continued to see encouraging advancements ... 43% quarter-over-quarter increase in estimated total prescriptions and ... mark," said Jack Lief, Arena,s President and Chief ...
Breaking Medicine Technology:Aspire Technology Partners Recognized By Cisco For Excellence In Customer Satisfaction 2NxStage to Present at the 34th Annual Canaccord Genuity Growth Conference 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 2Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 3Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 4Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 5Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 6Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 7Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 8Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 9Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 10Arena Pharmaceuticals Provides Corporate Update and Reports Second Quarter 2014 Financial Results 11
... DALLAS, June 23, 2011 , - ReportsnReports ... and,Combination Therapies , Report in its store ... Combination,Therapies , Report now! Search 75000+ ... , Pharmaceuticals Market Research Reports Report ...
... Inc., a privately held biotechnology company that develops immunotherapeutics ... announced that 1-year data from Protege, the Company,s Phase ... patients, will be presented at the American Diabetes Association,s ... June 28, 2011 at 9:10 a.m. PDT. ...
Cached Medicine Technology:ReportsnReports - Multitargeted Therapies: Promiscuous Drugs and Combination Therapies 2ReportsnReports - Multitargeted Therapies: Promiscuous Drugs and Combination Therapies 3ReportsnReports - Multitargeted Therapies: Promiscuous Drugs and Combination Therapies 4MacroGenics Announces Presentation of Protege Phase 3 Clinical Data at ADA in San Diego on June 28 2
(Date:8/1/2014)... New York, New York (PRWEB) August 01, 2014 ... ( http://www.gynecaremorcellatorlawsuit.com/ ) on behalf of women who allegedly ... use of power morcellators in gynecological surgeries, Bernstein Liebhard ... decision to withdraw a number of power morcellators marketed ... to a report from The New York Times, some ...
(Date:8/1/2014)... and the benefits of a cancer diagnosis may improve ... a study conducted by a researcher at the University ... an expressive writing intervention is the writing instruction. Otherwise, ... events. Writing a journal can be therapeutic, but oftentimes ... it,s effective or not," said Qian Lu, assistant professor ...
(Date:8/1/2014)... DELRAY BEACH, FL (PRWEB) August 01, 2014 ... hosted the 2014 California NextGen User Symposium in San ... event was held at the JW Marriott Union Square ... to help practices get up to speed with ACA ... said earlier this month. The symposium provides attendees guidance ...
(Date:8/1/2014)... August 01, 2014 According to ... by Geography (Asia-Pacific, North America, Europe, & ROW), ... by Fuel Type (Gasoline & Diesel), by After-Treatment ... - Trends & Forecasts to 2019", defines and ... an analysis of major countries in all the ...
(Date:8/1/2014)... (BRONX, NY) Scientists at Albert Einstein ... that bacteria that aid in digestion help keep the ... journal Immunity , could yield new therapies for ... other disorders. , The research involved the intestinal microbiome, ... these microorganisms in promoting or preventing disease is a ...
Breaking Medicine News(10 mins):Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 2Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 3Health News:Morcellator Lawsuit News: Bernstein Liebhard LLP Notes Reactions to Johnson & Johnson Power Morcellator Recall 4Health News:Expressive writing may help breast cancer survivors 2Health News:Expressive writing may help breast cancer survivors 3Health News:Quirk Healthcare Foundation Hosts Fifth Annual California NextGen User Symposium and Launches First Annual Florida NextGen User Symposium 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Exhaust Systems Market Will Be $33,379.7 Million by 2019 – New Report by MarketsandMarkets 4Health News:'Normal' bacteria vital for keeping intestinal lining intact 2
... Study found higher levels of staph, E. coli in ... News) -- Could common bacterial infections cause some cases of sudden ... of a study in this week,s issue of The Lancet ... levels of Staphylococcus aureus and Escherichia coli ...
... 29 Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ... joined the company as Vice President, International ... the development and,execution of clinical and regulatory ... candidates. Dr. Clarke was most recently,Vice President, ...
... MATK ) announced today that it will be ... Medical Technology,Conference in New York. The conference is being ... Palace Hotel. Peter L. Buzy, CFO is scheduled to ... Time., A live audio webcast of Martek,s presentation ...
... Ltd.,(Nasdaq: EMITF ) ("EI" or the "Company") today ... Loss for the first quarter of 2008 amounted to ... of NIS 27.3 million,(approximately US$ 7.7 million) is attributable ... NIS 23.8 million (approximately US$ 6.7,million) is attributable to ...
... the continued presence of a doula an experienced non-medical ... beneficial effects for middle- and upper-class women in childbirth, even ... with them, according to a new study in the journal ... of 420 pregnant women in their third trimester were randomized ...
... A critical enzyme used to prepare a powerful ... better target the cells the natural product attacks, according ... the Journal of Biological Chemistry. , Building on their ... Boston College and the University of Wisconsin, Madison discovered ...
Cached Medicine News:Health News:Bacterial Infection May Boost SIDS Risk 2Health News:Bacterial Infection May Boost SIDS Risk 3Health News:Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations 2Health News:Anthony Clarke, PhD Joins Alexza Pharmaceuticals as Vice President, International Development Operations 3Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 2Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 3Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 4Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 5Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 6Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 7Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 8Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 9Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 10Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 11Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 12Health News:Elbit Imaging Ltd. Announces First Quarter Results for 2008 13Health News:Enzyme may hold key to improved targeting of cancer-fighting drugs 2
... bring a new standard in the field of ... Labs. Made of medical grade silicone, these durable ... a high level of flexibility while maintaining correct ... available in varying stiffnesses. Lengths are determined by ...
... primary objective of the BioPro Toe implant ... will relieve pain and restore motion while ... undisturbed. The procedure used to implant the ... resection. , ,The design for the great ...
Ad-Techs Spinal Electrodes are intended for intraoperative monitoring of Evoked Potentials (EPs) of the descending pathway during spinal surgery. They are offered with 2 or 3 platinum contacts....
... of Ad-Techs products, our Sphenoidal Electrodes are manufactured ... available in stainless steel or platinum and feature ... (70 mm) long, 21 gauge (0.83 mm) introducing ... as kits or sets. You can also choose ...
Medicine Products: